**Robust post-COVID surveillance systems, including genomic sequencing and wastewater monitoring by WHO and CDC, combined with the absence of any novel pathogen showing sustained human-to-human transmission, underpin the market's 84% implied probability against a new pandemic before 2028.** Current threats such as H5N1 avian influenza, mpox, and localized Ebola outbreaks like the 2026 Bundibugyo event in Central Africa remain contained without crossing into efficient respiratory spread or global scale. Epidemiological data show respiratory infections pose the highest risk, yet UKHSA assessments place only moderate odds for a major influenza or coronavirus scenario over five years, reflecting improved detection and response capacity. Climate-driven vector expansion and zoonotic spillover potential introduce uncertainty, but no model consensus or observational shift signals imminent escalation within the narrow 2026–2027 window. Traders weigh these factors against historical baselines where most outbreaks are contained before pandemic thresholds.